British drug discovery specialist BenevolentAI Ltd has licenced its end-to-end AI platform capabilities to Merck KGaA to deliver novel drug candidates for three...
Disclaimer: This post is not investment advice of any kind; it is for informational purposes only. Neither BPT Analytics Ltd nor the authors of this...
Alphabet-owned Isomorphic Labs is ramping up its operations by poaching pharmaceutical talent and opening a new office, as the artificial intelligence drug discovery start-up...
A closer look at how companies can use IP for economic success and social impact and some of the on-going challenges they face in managing their IP assets.
The Covid-19 pandemic continues to grip the world this summer, with many lockdown restrictions remaining active around Europe. How has the European biotech...
